We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA |

Highlights FREE

JAMA. 2014;311(23):2355-2357. doi:10.1001/jama.2013.279556.
Text Size: A A A
Published online


Physical Activity to Prevent Major Mobility Disability

In a randomized trial that enrolled 1635 sedentary adults aged 70 to 89 years who had physical limitations but were able to walk 400 meters, Pahor and colleagues found that compared with a health education program, a long-term structured physical activity program that involved aerobic, resistance, and flexibility training reduced the occurrence of incident major mobility disability over 2.6 years.

Selumetinib vs Chemotherapy and Survival in Uveal Melanoma

Uveal melanoma is characterized by gene mutations that activate the mitogen-activated protein kinase (MAPK) pathway. In a randomized trial that enrolled 101 patients with metastatic uveal melanoma, Carvajal and colleagues found that compared with chemotherapy, selumetinib—a selective inhibitor of the MAPK pathway—resulted in a modest improvement in progression-free but not overall survival.

TNF-α Antagonists and Cancer Risk in Patients With IBD

Tumor necrosis factor α (TNF-α) antagonists are effective in the treatment of inflammatory bowel disease (IBD); however, there is concern that treatment-induced immunosuppression may increase the risk of cancer. In a nationwide study from Denmark that included 56 146 patients with IBD (4553 with TNF-α antagonist exposure), Andersen and colleagues found no increased risk of cancer associated with TNF-α antagonist exposure during a median follow-up of 3.7 years.

Thrombolytic Therapy for Pulmonary Embolism

To assess mortality and bleeding risks associated with thrombolytic therapy vs anticoagulation in acute pulmonary embolism, Chatterjee and colleagues performed a meta-analysis of data from 16 randomized trials (2115 patients)—including 8 trials (n=1775) of patients who were hemodynamically stable with right ventricular dysfunction (intermediate-risk pulmonary embolism). Among the authors’ findings was that thrombolytic therapy was associated with lower rates of all-cause mortality and increased risks of major bleeding and intracranial hemorrhage. In an Editorial, Beckman discusses thrombolysis in patients with pulmonary embolism.


Does This Patient Have an Exudative Pleural Effusion?

Thoracentesis is performed to identify the cause of a pleural effusion. In a systematic review of data from 48 studies that examined diagnostic tests for differentiating pleural exudates from transudates, Wilcox and colleagues found that pleural fluid cholesterol and lactate dehydrogenase levels, the pleural fluid cholesterol to serum cholesterol ratio, and Light’s criteria were the most accurate diagnostic indicators for pleural exudates.

Exercise for Depression

Exercise is sometimes considered an adjunct or substitute for pharmacological or psychological treatment of depression. In this JAMA Clinical Evidence Synopsis, Cooney and colleagues summarize a Cochrane review of 39 randomized trials of exercise as a treatment for depression. The authors found that compared with no treatment, placebo, or an active control intervention such as relaxation or meditation, exercise was associated with a greater reduction in depressive symptoms. However, analysis of 6 high-quality studies (464 participants) suggested the benefit of exercise is small.

Lung Opacification

A 16-year-old girl presents with acute left shoulder pain, left-sided chest pain, and shortness of breath. Similar pain symptoms had been present intermittently for 4 months. Examination reveals tenderness over the left fifth rib and reduced left chest expansion without a chest wall deformity. A chest x-ray shows left lower lobe opacification. What would you do next?



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.